Azithromycin and doxycycline not beneficial in managing covid

Results from the RECOVERY trial and the PRINCIPLE trial have shown no significant clinical benefit of


· oral or intravenous azithromycin in patients hospitalised with COVID-19

· oral azithromycin in patients with early stages of COVID-19 managed at home

Results from the PRINCIPLE trial have additionally shown there is no significant clinical benefit of oral doxycycline in patients with early stages of COVID-19 managed at home.


Within primary care it is recommended azithromycin or doxycycline should NOT be used in the primary management of COVID-19 infection.

3 views0 comments

Recent Posts

See All

Hornsey Rise Health Centre, Hornsey Rise, N19 3YU

nhs-choices.png

CQC ID:1-538904390

care_quality_commission_logo.png

© 2020 by The Beaumont Practice 

FULL WHEELCHAIR ACCESS

  • Instagram
  • White Facebook Icon
  • White Twitter Icon